Cargando…

Intravenous-to-oral antibiotic switch therapy: a cross-sectional study in critical care units

BACKGROUND: This study aimed to evaluate the oral switch (OS) stewardship intervention in the intensive care unit (ICU). METHODS: This was a retrospective study with a convenience sample in two Brazilian ICUs from different hospitals in patients with sepsis receiving antibiotic therapy. The stewards...

Descripción completa

Detalles Bibliográficos
Autores principales: Gasparetto, Juliano, Tuon, Felipe Francisco, dos Santos Oliveira, Dayana, Zequinao, Tiago, Pipolo, Gabriel Rammert, Ribeiro, Gabriel Velloso, Benincá, Paola Delai, Cruz, June Alisson Westarb, Moraes, Thyago Proenca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6647098/
https://www.ncbi.nlm.nih.gov/pubmed/31331272
http://dx.doi.org/10.1186/s12879-019-4280-0
Descripción
Sumario:BACKGROUND: This study aimed to evaluate the oral switch (OS) stewardship intervention in the intensive care unit (ICU). METHODS: This was a retrospective study with a convenience sample in two Brazilian ICUs from different hospitals in patients with sepsis receiving antibiotic therapy. The stewardship intervention included OS in patients diagnosed with sepsis when clinical stability was achieved. The primary outcome was overall mortality. Other variables evaluated were as follows: cost of antimicrobial treatment, daily costs of intensive care, acute kidney injury, and length of stay. RESULTS: There was no difference in mortality between the OS and non-OS groups (p = 0.06). Length of stay in the ICU (p = 0.029) was shorter and acute kidney injury incidence (p = 0.032) and costs of antimicrobial therapy (p < 0.001) were lower in the OS group. CONCLUSION: OS stewardship programs in the ICU may be considered a safe strategy. Switch therapy reduced the cost and shortened the length of stay in ICUs. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12879-019-4280-0) contains supplementary material, which is available to authorized users.